Drug wrecks the power plants of cancer cells

Researchers have identified a compound that selectively kills tumor cells by destroying their metabolic power plants. The researchers believe that the compound, code-named F16, could serve as a model for a targeted chemotherapy with low toxicity.

In an article published in the July 2002 issue of the journal Cancer Cell, researchers led by Howard Hughes Medical Institute senior investigator Philip Leder at Harvard Medical School reported that they screened 16,000 small molecules to look for compounds that would have a favorable effect on transgenic mouse cells engineered to overexpress the cancer-causing gene neu. The human counterpart of neu, which is called HER-2, has been implicated in 20-30 percent of human breast cancers, and is linked with a poor prognosis for breast cancer treatment.

"Because neu or its human analog are such important elements in breast cancer, we decided to carry out these experiments to identify metabolic pathways that might collaborate with HER-2 or neu in the development of malignancy," said Leder.

In the experiments, the paper's lead author, HHMI associate Valeria R. Fantin, introduced the neu gene into mouse mammary epithelial cells. Mouse mammary epithelial cells that overexpress neu bear some of the characteristics of human breast tumors. Fantin then tested each of the 16,000 molecules to see how it affected the growth of the transgenic and normal mouse cells. These studies showed that F16 selectively inhibited the growth of the neu-overexpressing cells, but not the normal cells.

Additional studies indicated that F16 also inhibited the proliferation of a number of mouse cancer-cell lines that were derived in Leder's laboratory and a panel of human breast cancer cell lines. The researchers found that F16 prevented the formation of tumors that would normally occur when '"/>

Contact: Jim Keeley
Howard Hughes Medical Institute

Page: 1 2 3

Related biology news :

1. Ecowar looming with sunken wartime wrecks
2. Green, leafy spinach may soon power cellphones and laptops
3. Wastewater could treat itself, power city
4. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
5. Coordinating power of circadian rhythms keeps estrus and pregnancy on track
6. FDA approves VYTORIN, first and only to powerfully reduce LDL cholesterol through dual inhibition
7. Spanish scientists develop powerful tool for exploration and integration of biological information
8. Volcanic soils yield new clues about the emergence of powerful chiefdoms in Hawaii
9. Motion that powers sperm provides key to unravelling rare genetic disorder
10. Ethanol to power the future of hydrogen fuel cells
11. A shocking surprise: High voltage + rats = ozone, reopens power-line debate

Post Your Comments:

(Date:2/6/2019)... , ... February 04, 2019 , ... ... new Explorer™ story which provides insights to help individuals understand how the gut ... cardiovascular wellness. , After individuals eat foods that contain choline and L-carnitine, ...
(Date:2/2/2019)... ... January 31, 2019 , ... Aperio ... customizable clinical research services across multiple therapeutic areas, announced an Innovation Partner ... life science entrepreneurs in the Research Triangle region of North Carolina. ...
(Date:1/25/2019)... ... January 24, 2019 , ... GrowthZone, Inc., ... Survey. The report indicates membership growth in some sectors and decreasing membership among ... received responses from over 500 association professionals across North America. , “This ...
Breaking Biology News(10 mins):
(Date:1/15/2019)... ... 2019 , ... Personalized treatment plans may extend life expectancy for early-stage kidney ... study published in the journal Radiology. , Kidney, or renal, tumors are often ... procedure in which the tumor and part of the kidney are removed. However, some ...
(Date:1/11/2019)... ... ... Drawing on over 22 years of software development expertise, the live webinar ... the key lessons that have driven customer satisfaction with their eClinical suite. Explore the ... how to ensure that you continue to be able to take advantage of the ...
(Date:1/10/2019)... ... 2019 , ... VGI Medical was founded in 2007 based on an invention ... the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are ... dual geometric design to limit motion of the affected spinal segment. Applying the principles ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... 1 clinical trials of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 ... Parkinson's Disease. The trial took place in South Korea. , This Phase ...
Breaking Biology Technology:
Cached News: